| Strategies to overcome acquired resistance to EGFR TKI in the treatment of non-small cell lung cancer |
24 |
| Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy |
21 |
| Ki67 targeted strategies for cancer therapy |
21 |
| Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients |
20 |
| The role of immunotherapy in small cell lung cancer |
17 |
| Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization |
16 |
| Reduction-oxidation (redox) system in radiation-induced normal tissue injury: molecular mechanisms and implications in radiation therapeutics |
15 |
| SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018) |
15 |
| Pretreatment neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte, and neutrophil/monocyte ratios and outcome in elderly breast cancer patients |
14 |
| Nutritional support and parenteral nutrition in cancer patients: an expert consensus report |
14 |
| A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study |
14 |
| Cancer survival in adult patients in Spain. Results from nine population-based cancer registries |
13 |
| Inhibiting 6-phosphogluconate dehydrogenase selectively targets breast cancer through AMPK activation |
12 |
| MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer |
12 |
| Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology |
12 |
| Hypoxia-induced LncRNA PCGEM1 promotes invasion and metastasis of gastric cancer through regulating SNAI1 |
12 |
| Efficacy of nintedanib and docetaxel in patients with advanced lung adenocarcinoma treated with first-line chemotherapy and second-line immunotherapy in the nintedanib NPU program |
11 |
| Multiple sclerosis outcomes after cancer immunotherapy |
11 |
| SEOM clinical guidelines on nutrition in cancer patients (2018) |
11 |
| The microRNA signatures: aberrantly expressed miRNAs in prostate cancer |
11 |
| Pancreaticoduodenectomy for periampullary tumours: a review article based on Surveillance, End Results and Epidemiology (SEER) database |
10 |
| The absolute lymphocyte count can predict the overall survival of patients with non-small cell lung cancer on nivolumab: a clinical study |
10 |
| Factors associated with anxiety and depression in cancer patients prior to initiating adjuvant therapy |
10 |
| Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients |
10 |
| Evaluation of safety and efficacy of p53MVA vaccine combined with pembrolizumab in patients with advanced solid cancers |
10 |
| Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives |
10 |
| The dual effect of morphine on tumor development |
10 |
| Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients' preference-based study (PPPS) |
10 |
| SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017) |
9 |
| Acquired temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine |
9 |
| Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma |
9 |
| Circular RNAs and exosomes in cancer: a mysterious connection |
9 |
| CalliSpheres (R) drug-eluting beads (DEB) transarterial chemoembolization (TACE) is equally efficient and safe in liver cancer patients with different times of previous conventional TACE treatments: a result from CTILC study |
9 |
| miR-328 mediates a metabolic shift in colon cancer cells by targeting SLC2A1/GLUT1 |
8 |
| Inhibiting ERK/Mnk/eIF4E broadly sensitizes ovarian cancer response to chemotherapy |
8 |
| Inhibiting 6-phosphogluconate dehydrogenase enhances chemotherapy efficacy in cervical cancer via AMPK-independent inhibition of RhoA and Rac1 |
8 |
| Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS |
8 |
| SEOM clinical guidelines in early stage breast cancer (2018) |
8 |
| SEOM clinical guideline in nasopharynx cancer (2017) |
8 |
| SEOM clinical guideline for treatment of cancer pain (2017) |
8 |
| Analysis of blood markers for early breast cancer diagnosis |
8 |
| The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients |
7 |
| A candidate for lung cancer treatment: arsenic trioxide |
7 |
| Quality of life after whole brain radiotherapy compared with radiosurgery of the tumor bed: results from a randomized trial |
7 |
| SEOM clinical guideline on unknown primary cancer (2017) |
7 |
| Data from real world to evaluate the efficacy of osimertinib in non-small cell lung cancer patients with central nervous system metastasis |
7 |
| Role of intestinal microbiome in American ginseng-mediated colon cancer protection in high fat diet-fed AOM/DSS mice |
7 |
| Assessing predicted age-specific breast cancer mortality rates in 27 European countries by 2020 |
7 |
| Hydrogen peroxide-induced mitophagy contributes to laryngeal cancer cells survival via the upregulation of FUNDC1 |
7 |
| Efficacy of Huaier granule in patients with breast cancer |
7 |
